Invenomic Capital Management’s Viant Technology DSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Sell
207,258
-69,632
-25% -$785K 0.16% 97
2026
Q1
$3.1M Buy
276,890
+48,674
+21% +$538K 0.14% 120
2025
Q4
$2.75M Buy
+228,216
New +$2.28M 0.13% 127
2024
Q2
Sell
-52,589
Closed -$561K 171
2024
Q1
$561K Sell
52,589
-386,782
-88% -$3.37M 0.03% 142
2023
Q4
$3.03M Sell
439,371
-92,496
-17% -$556K 0.14% 131
2023
Q3
$2.98M Sell
531,867
-175,038
-25% -$958K 0.13% 113
2023
Q2
$3.26M Sell
706,905
-96,485
-12% -$427K 0.17% 103
2023
Q1
$3.49M Hold
803,390
0.2% 109
2022
Q4
$3.23M Sell
803,390
-29,897
-4% -$121K 0.22% 107
2022
Q3
$3.51M Sell
833,287
-157,626
-16% -$772K 0.3% 94
2022
Q2
$5.03M Buy
990,913
+329,859
+50% +$1.98M 0.36% 80
2022
Q1
$4M Buy
+661,054
New +$5.04M 0.43% 70

Other funds holding DSP

Invenomic Capital Management's DSP Position: Q2 2026 in Review

Invenomic Capital Management reduced its Viant Technology (DSP) stake by 25% in Q2 2026, selling an estimated $785K and leaving 207,258 shares worth $2.62M. The position accounts for 0.16% of the portfolio, ranked #97.

Invenomic Capital Management first reported a position in DSP in Q1 2022 and has held it in 12 quarters since. The position peaked at $5.03M in Q2 2022. 121 funds tracked by Wall St. Rank hold DSP as of Q2 2026.

  • Invenomic Capital Management held 207,258 shares of Viant Technology worth $2.62M as of Q2 2026.
  • Invenomic Capital Management sold 69,632 Viant Technology shares in Q2 2026, an estimated $785K.
  • Viant Technology made up 0.16% of Invenomic Capital Management's portfolio in Q2 2026, its #97 holding.
  • Invenomic Capital Management first reported a position in Viant Technology in Q1 2022 and has held it in 12 quarters since.
  • Invenomic Capital Management's Viant Technology position peaked at $5.03M in Q2 2022.
  • 121 funds tracked by Wall St. Rank held Viant Technology as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.